Share Email Print
cover

Proceedings Paper

Measurement of changes in blood oxygenation using Multispectral Optoacoustic Tomography (MSOT) allows assessment of tumor development
Author(s): Michal R. Tomaszewski; Isabel Quiros-Gonzalez; James Joseph; Sarah E. Bohndiek
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

The ability to evaluate tumor oxygenation in the clinic could indicate prognosis and enable treatment monitoring, since oxygen deficient cancer cells are more resistant to chemotherapy and radiotherapy. MultiSpectral Optoacoustic Tomography (MSOT) is a hybrid technique combining the high contrast of optical imaging with the spatial resolution and penetration depth similar to ultrasound. We aim to demonstrate that MSOT can be used to monitor the development of tumor vasculature.

To establish the relationship between MSOT derived imaging biomarkers and biological changes during tumor development, we performed MSOT on nude mice (n=10) bearing subcutaneous xenograft U87 glioblastoma tumors using a small animal optoacoustic tomography system. The mice were maintained under inhalation anesthesia during imaging and respired oxygen content was modified between 21% and 100%. The measurements from early (week 4) and late (week 7) stages of tumor development were compared. To further explore the functionality of the blood vessels, we examined the evolution of changes in the abundance of oxy- and deoxyhemoglobin in the tumors in response to a gas challenge. We found that the kinetics of the change in oxygen saturation (SO2) were significantly different between small tumors and the healthy blood vessels in nearby normal tissue (p=0.0054). Furthermore, we showed that there was a significant difference in the kinetics of the gas challenge between small and large tumors (p=0.0015). We also found that the tumor SO2 was significantly correlated (p=0.0057) with the tumor necrotic fraction as assessed by H&E staining in histology. In the future, this approach may be of use in the clinic as a method for tumor staging and assessment of treatment response.

Paper Details

Date Published: 15 March 2016
PDF: 8 pages
Proc. SPIE 9708, Photons Plus Ultrasound: Imaging and Sensing 2016, 97081F (15 March 2016); doi: 10.1117/12.2208913
Show Author Affiliations
Michal R. Tomaszewski, Cavendish Lab. (United Kingdom)
Cancer Research UK Cambridge Institute (United Kingdom)
Isabel Quiros-Gonzalez, Cancer Research UK Cambridge Institute (United Kingdom)
James Joseph, Cavendish Lab. (United Kingdom)
Cancer Research UK Cambridge Institute (United Kingdom)
Sarah E. Bohndiek, Cavendish Lab. (United Kingdom)
Cancer Research UK Cambridge Institute (United Kingdom)


Published in SPIE Proceedings Vol. 9708:
Photons Plus Ultrasound: Imaging and Sensing 2016
Alexander A. Oraevsky; Lihong V. Wang, Editor(s)

© SPIE. Terms of Use
Back to Top